A role in tumor development in patients with T2DM is also being investigated but further studies are required to fully understand the functions of GLP-1R and its agonists
Sulfonylureas blockade of neural and cardiac HERG channels
Doctors may need to monitor patients to ensure they do not lose excessive weight
However, stopping Semaglutide can lead to withdrawal symptoms such as increased appetite, elevated blood sugar levels, weight gain, and cardiovascular changes
However, the question of whether GLP-1 drugs might indirectly contribute to yeast infection risk requires nuanced consideration
Mokhtari, E., Rafiei, S., Shokri-Mashhadi, N., & Saneei, P